High Tower Advisors, LLC Adamis Pharmaceuticals Corp Call Options Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 10, 2022	BUY	$0.34 - $0.57 $26,259 - $44,023	77,235 Added 10096.08%	78,000 $14,000
Q1 2022 May 12, 2022	SELL	$0.55 - $0.73 $13,879 - $18,421	-25,235 Reduced 97.06%	765 $11,000
Q2 2021 Aug 06, 2021	BUY	$0.66 - $1.23 $16,170 - $30,135	24,500 Added 1633.33%	26,000 $12,000
Q3 2018 Nov 09, 2018	BUY	$2.25 - $4.8 $1,125 - $2,400	500 Added 50.0%	1,500 $0
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $3,500 - $5,650	1,000	1,000 $0

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.